Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study.

Maria PetraccaSerena RuggieriElena BarbutiAntonio IannielloRoberta FantozziGiorgia Teresa ManiscalcoVincenzo AndreoneDoriana LandiGirolama Alessandra MarfiaMaria Di GregorioRosa IodiceLeonardo SinisiElisabetta MaidaRosanna MissioneCinzia CoppolaSimona BonavitaGiovanna BorrielloDiego CentonzeGiacomo LusCarlo PozzilliElisabetta Signoriello

Published in: Neurology and therapy (2022)

In this large cohort, we confirm previous data about cladribine effectiveness on disease activity and disability worsening and provide information on response predictors that might inform therapeutic choices.

Keyphrases

disease activity
multiple sclerosis
rheumatoid arthritis
systemic lupus erythematosus
rheumatoid arthritis patients
ankylosing spondylitis
juvenile idiopathic arthritis
randomized controlled trial
systematic review
electronic health record
cross sectional
big data
machine learning
health information